Paydirt
JA
Insider

Jeffrey W. Albers

Director

Jeffrey W. Albers (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BPMC. The largest single filing was $2.4M of SYRE (23,000 sh across 3 lots, as filed), executed Aug 7.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.1M
shares × price, as filed
Last traded
Aug 7
Filed Aug 10

Median ADV $118.2M across their filed names

Open performance→
Volume by month
$2.4M$1.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $756KDec 2024 · sells $1.3MJan 2025 · sells $2.1MMar 2025 · sells $1.2MMay 2025 · sells $439KJun 2025 · sells $311KOct 2025 · sells $296KDec 2025 · sells $449KAug 2026 · sells $2.4M
Buys $0 Sells $9.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
BPMC BPMC BPMC · 0 buys · 7 sells 7 filings KYMR Kymera Therapeutics, Inc. KYMR · 0 buys · 3 sells 3 filings SYRE Spyre Therapeutics, Inc. SYRE · 0 buys · 2 sells 2 filings
Recent filings
BPMCSALE Blueprint Medicines Corp View filing → $511K
5,000 sh × $102.28
Exec Jan 13 2025
Filed Jan 15 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $1.3M
15,000 sh across 4 lots
Exec Dec 19 2024
Filed Dec 20 2024 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $510K
5,000 sh × $102.00
Exec Nov 7 2024
Filed Nov 12 2024 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $246K
6,700 sh × $36.76
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $1.7M
19,702 sh across 2 lots
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET